X
Xilio Therapeutics D
D
XLO
0.66230
USD
-0.00
(-0.48%)
مغلق
حجم التداول
19,628
الربح لكل سهم
-4
العائد الربحي
-
P/E
-1
حجم السوق
34,295,399
الأخبار المقالات
العنوان: Xilio Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).